Delivery of immune response modifier compounds

Details for Australian Patent Application No. 2004268616 (hide)

Owner 3M Innovative Properties Company

Inventors Kedl, Ross M.; Wolter, James T.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004268616

PCT Pub. Number WO2005/020912

Priority 60/497,628 25.08.03 US

Filing date 25 August 2004

Wipo publication date 10 March 2005

Acceptance publication date 7 October 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

16 March 2006 PCT application entered the National Phase

  PCT publication WO2005/020912 Priority application(s): WO2005/020912

7 October 2010 Application Accepted

  Published as AU-B-2004268616

3 February 2011 Standard Patent Sealed

22 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004268618-Apparatus and method for liquid sample partitioning

2004268614-Combination therapy for the treatment of ocular neovascular disorders